Evidence map›Paper›PMID 36574263›Full record

ArticleAnalytical chemistry2023

FULL-MDS: Fluorescent Universal Lipid Labeling for Microfluidic Diffusional Sizing.

Jasmin Baron, Lena Bauernhofer, Sean R A Devenish, Sebastian Fiedler, Alison Ilsley, Sabrina Riedl, Dagmar Zweytick, David Glueck, Ariane Pessentheiner, Grégory Durand and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Discovery of Therapeutic Antibodies Targeting Complex Multi-Spanning Membrane Proteins.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2024
    Review
  7. Article
  8. Effect of Cholesterol on the Structure and Composition of Glyco-DIBMA Lipid Particles.Langmuir : the ACS journal of surfaces and colloids · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jasmin BaronBiophysics, Institute of Molecular Biosciences (IMB), NAWI Graz, University of Graz, Humboldtstr. 50/III, Graz 8010, Austria.
Lena BauernhoferBiophysics, Institute of Molecular Biosciences (IMB), NAWI Graz, University of Graz, Humboldtstr. 50/III, Graz 8010, Austria.ORCID 0000-0001-9980-9683
Sean R A DevenishThe Paddocks Business Centre, Fluidic Analytics Ltd., Unit A, Cherry Hinton Road, Cambridge CB1 8DH, United Kingdom.
Sebastian FiedlerThe Paddocks Business Centre, Fluidic Analytics Ltd., Unit A, Cherry Hinton Road, Cambridge CB1 8DH, United Kingdom.ORCID 0000-0003-0953-4327
Alison IlsleyThe Paddocks Business Centre, Fluidic Analytics Ltd., Unit A, Cherry Hinton Road, Cambridge CB1 8DH, United Kingdom.
Sabrina RiedlBiophysics, Institute of Molecular Biosciences (IMB), NAWI Graz, University of Graz, Humboldtstr. 50/III, Graz 8010, Austria.ORCID 0000-0002-2608-0753
Dagmar ZweytickBiophysics, Institute of Molecular Biosciences (IMB), NAWI Graz, University of Graz, Humboldtstr. 50/III, Graz 8010, Austria.
David GlueckBiophysics, Institute of Molecular Biosciences (IMB), NAWI Graz, University of Graz, Humboldtstr. 50/III, Graz 8010, Austria.ORCID 0000-0003-3983-1277
Ariane PessentheinerBiophysics, Institute of Molecular Biosciences (IMB), NAWI Graz, University of Graz, Humboldtstr. 50/III, Graz 8010, Austria.
Grégory DurandEquipe Synthèse et Systèmes Colloïdaux Bio-organiques, Unité Propre de Recherche et d'Innovation, Avignon Université, 301 rue Baruch de Spinoza, Avignon 84916 CEDEX 9, France.ORCID 0000-0001-6680-2821
Sandro KellerBiophysics, Institute of Molecular Biosciences (IMB), NAWI Graz, University of Graz, Humboldtstr. 50/III, Graz 8010, Austria.ORCID 0000-0001-5469-8772
University of Graz · ATUniversité d'Avignon et des Pays de Vaucluse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microfluidic diffusional sizing (MDS) is a recent and powerful method for determining the hydrodynamic sizes and interactions of biomolecules and nanoparticles. A major benefit of MDS is that it can report the size of a fluorescently labeled target even in mixtures with complex, unpurified samples. However, a limitation of MDS is that the target itself has to be purified and covalently labeled with a fluorescent dye. Such covalent labeling is not suitable for crude extracts such as native nanodiscs directly obtained from cellular membranes. In this study, we introduce fluorescent universal lipid labeling for MDS (FULL-MDS) as a sparse, noncovalent labeling method for determining particle size. We first demonstrate that the inexpensive and well-characterized fluorophore, Nile blue, spontaneously partitions into lipid nanoparticles without disrupting their structure. We then highlight the key advantage of FULL-MDS by showing that it yields robust size information on lipid nanoparticles in crude cell extracts that are not amenable to other sizing methods. Furthermore, even for synthetic nanodiscs, FULL-MDS is faster, cheaper, and simpler than existing labeling schemes.

Indexed as

Fluorescent DyesMicrofluidicsCell MembraneLipidsFluorescent DyesLipids

Identifiers

PMID36574263
PMCPMC9850350
OpenAlexW4312210617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.